about
sameAs
Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantationThe cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host diseaseSplicing factor SF3B1K700E mutant dysregulates erythroid differentiation via aberrant alternative splicing of transcription factor TAL1.CCR2 is required for CD8-induced graft-versus-host disease.Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestineKeratinocyte growth factor (KGF) is required for postnatal thymic regeneration.Absence of donor T-cell-derived soluble TNF decreases graft-versus-host disease without impairing graft-versus-tumor activityRelapse after allogeneic hematopoietic cell therapy.STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host disease.Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation.Genetic drivers of vulnerability and resistance in relapsed acute lymphoblastic leukemia.Cytolytic T cells induce ceramide-rich platforms in target cell membranes to initiate graft-versus-host disease.Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML.Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunity.Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations
P50
Q27334243-FC0E3DFE-B183-4832-93E4-B4AC7F13B242Q33559627-8FA164E8-F9E2-4EED-A92C-AAA5F8A1E75DQ33703520-8D5D7847-1D1C-4065-BE4C-8FDE050ECF95Q35848441-2D0AA4C0-EB05-4742-9334-5F7A853E519FQ35848654-428450CA-D793-4F4D-B84D-D0D10EBE0646Q35849533-18541E6D-9685-4212-B0C5-8DB15189F535Q35900973-81937511-E61B-4382-A20C-A860DDDEF0F1Q36799799-58068B0D-4465-4E34-BFE6-E60840C3D698Q37003577-C14A0955-0335-40BF-8982-A655F750A993Q37100759-A5DAE8EA-3A5F-4AF9-8556-8B5FD81F8516Q37322952-25673349-10BB-4DBE-AA8C-B8AC4748B24EQ37398338-C83706BB-2FE1-410E-8EBB-57518908B06AQ38747542-258E3DB6-EA56-4DA1-B87D-A46EB7302181Q40278217-942DD845-B78E-4ECC-8CA2-6A581D6A3E57Q63649314-ED79696D-4004-48DF-A3CE-AD4E6D2C4914
P50
description
researcher ORCID ID = 0000-0002-2217-1674
@en
wetenschapper
@nl
name
Sydney S Lu
@ast
Sydney S Lu
@en
Sydney S Lu
@nl
type
label
Sydney S Lu
@ast
Sydney S Lu
@en
Sydney S Lu
@nl
prefLabel
Sydney S Lu
@ast
Sydney S Lu
@en
Sydney S Lu
@nl
P106
P31
P496
0000-0002-2217-1674